In conversation with...

Sarah Tabrizi and Cristina Sampaio on classifying Huntington's and new therapies

June 15, 2022 The Lancet Neurology
In conversation with...
Sarah Tabrizi and Cristina Sampaio on classifying Huntington's and new therapies
Show Notes

Sarah Tabrizi (UCL Queen Square Institute of Neurology, London, UK) and Cristina Sampaio (CHDI Foundation, Princeton, NJ, USA) discuss two papers on Huntington’s disease published in the July issue of The Lancet Neurology: a Position Paper outlining a new classification of the disease, called the Huntington’s Disease Integrated Staging System, and a Personal View on potential disease-modifying therapies.